EP0220339B1 - Dérivés d'azabicycloalkyl - Google Patents

Dérivés d'azabicycloalkyl Download PDF

Info

Publication number
EP0220339B1
EP0220339B1 EP85115575A EP85115575A EP0220339B1 EP 0220339 B1 EP0220339 B1 EP 0220339B1 EP 85115575 A EP85115575 A EP 85115575A EP 85115575 A EP85115575 A EP 85115575A EP 0220339 B1 EP0220339 B1 EP 0220339B1
Authority
EP
European Patent Office
Prior art keywords
compound
formula
methyl
mixture
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP85115575A
Other languages
German (de)
English (en)
Other versions
EP0220339A1 (fr
Inventor
Michael Stewart Hadley
Francis David King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of EP0220339A1 publication Critical patent/EP0220339A1/fr
Application granted granted Critical
Publication of EP0220339B1 publication Critical patent/EP0220339B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Definitions

  • This invention relates to novel intermediates of use in the preparation of pharmacologically active compounds.
  • N - (2 - Diethylaminoethyl) - 2 - methoxy - 4 - amino - 5 - chlorobenzamide, 1 - ethyl - 2(methoxy - 5 - sulphamoylbenzamidomethyl)pyrrolidine and N - [4' - (1" - benzyl) - piperidyl] - 2 - methoxy - 4 - amino - 5 - chlorobenzamide are well known compounds having useful pharmacological activity such as the ability to regulate the gastro-intestinal function, anti-emetic activity and CNS activity.
  • European Patent 13138 describes a process for the preparation of a compound of the formula (I) as defined therein, which process comprises reacting an acid of the formula (XII): or a reactive derivative thereof, with an intermediate compound of formula (XIIIA) as hereinbefore defined; and thereafter if desired or necessary converting a group R 2 or R 3 in the thus formed compound to another group R 2 or R 3 respectively; and optionally forming a pharmaceutically acceptable salt of the resultant compound of the formula (I).
  • the ⁇ CO ⁇ NR 5 ⁇ (CH 2 ) n ⁇ linkage may have an a or ⁇ orientation with respect to the ring of the bicyclic moiety to which it is attached.
  • a mixture of a and ⁇ isomers of the compound of the formula (1) may be synthesised nonstereospecifically and the desired isomer separated conventionally therefrom, e.g. by chromatography; or alternatively the a or ⁇ isomer may if desired be synthesised from the corresponding a or ⁇ form of the compound of the formula (XIIIA).
  • the a or ⁇ form of a compound of formula (XIIIA) may be prepared by known stereospecific processes, such as those leading to the a or ⁇ isomer of the compound of formula (XIIIA) depicted in Scheme 1 of EP 81054.
  • the precursor of a compound of formula (XIII) may be stereospecifically synthesised, such as via the azide, and then converted to the corresponding desired isomer of the compound of formula (XIIIA) under non-stereospecific conditions with retention of configuration.
  • the precursor may itself have no asymmetric centre at the relevant position, such as oximes and imines, but may be converted under stereospecific conditions to the desired isomer of the compound of formula (XIIIA).
  • a mixture of the a or ⁇ isomers of a compound of formula (XIIIA) may be synthesised non-stereospecifically and the desired isomer separated conventionally therefrom e.g. by chromatography.
  • Schemes 1 and 2 of EP 81054 illustrate stereospecific and non-stereospecific synthetic routes to the intermediates of formula (XIIIA) wherein n is 0 and wherein n is 1 or 2, respectively.
  • Tropane is 8-methyl-8-azabicyclo[3.2.1]octane and derivatives thereof are named accordingly in the following.
  • Tropinone (3.68 g; 0.0265 mole) was dissolved in ethanol (50 ml) containing pyridine (4-5 ml) and treated with hydroxylamine hydrochloride (1.90 g). The mixture was heated under reflux for 30 minutes, cooled, treated with solid potassium carbonate (ca. 10 g) and water (ca..5 ml). The ethanol was removed in vacuo and the mixture extracted with chloroform (3 x 150 ml). The combined extracts were dried (K,C0 3 ), filtered and evaporated in vacuo. The resulting solid was recrystallised from ethyl acetate/petrol ether 40-60 to yield tropinone oxime (3.1 g; 76%) as colorless crystals m.pt. 114 ⁇ 115°C.
  • Tropinone oxime (3.08 g; 0.02 mole) was dissolved in anhydrous amyl alcohol (100 ml) and heated to almost boiling. Sodium (ca. 3.0 g) was added portionwise over 1 hour then the mixture left to cool overnight. The mixture was treated with 5N hydrochloric acid (ca. 80 ml), and extracted with ethyl acetate (3 x 150 ml).
  • N-Methyl-9-azabicyclo[3.3.1]nonan-3-one oxime (3.25 g, 0.02 mole) was dissolved in ethanol and hydrogenated over Raney nickel in the presence of ammonium acetate at 300 p.s.i. 2.02 MPa at 50°C for 24 hours. The mixture was filtered, evaporated in vacuo, dissolved in dilute hydrochloric acid, basified and extracted into ethyl acetate. The combined organic layers were dried (K 2 C0 3 ), filtered and evaporated in vacuo to yield 3-amino-9-methyl-9-azabicyclo[3.3.1]nonane (2.67 g, 90%), used without further purification.
  • the product was a single diastereomer believed to be the a-isomer; which is endo-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine.
  • Methyl isocyanide (5.04 g, 0.026 mol) was added to ( ⁇ )-tropan-2-one (2 g, 0.143 mol) in dimethoxyethane (80 ml) and the solution cooled to 0°C. Ethanol (2 ml) was added followed by addition of potassium tert-butoxide (5.64 g, 6.05 mol). The mixture was then heated at 50°C for three hours, cooled and poured into a saturated potassium carbonate solution (300 ml).
  • the product is a racemate of a single diastereomer, believed to be the ( ⁇ )-a-isomer.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (9)

1. Composé, caractérisé par la formule (XIIIA)
Figure imgb0010
dans laquelle
R5 est un atome d'hydrogène ou un groupe alkyle en C1-6;
R6 est un groupe alkyle en Cl-4; et
n, p et q sont indépendamment 0 à 2;
à la condition que dans la cas où n est égal à zéro, p soit 1 ou 2.
2. Composé suivant la revendication 1, caractérisé en ce que Rs est un atome d'hydrogène.
3. Composé suivant l'une quelconque des revendications précédentes, caractérisé en ce que n est égal à zéro.
4. Composé suivant l'une quelconque des revendications précédentes, caractérisé en ce que p est égal à zéro ou un.
5. Composé suivant l'une quelconque des revendications précédentes, caractérisé en ce que q est égal à un.
6. Composé suivant la revendication 5, caractérisé en ce que la partie HR5N―(CH2)n est fixée au noyeu bicyclique en position para par rapport à la partie N―R6.
7. Composé suivant la revendication 6, caractérisé en ce que la partie HR5N―(CH2)n a une orientation a par rapport au noyau bicyclique auquel elle est attachée.
8. Composé suivant l'une quelconque des revendications précédentes, caractérisé en ce que R6 est un groupe méthyle ou éthyle.
9. Composé suivant la revendication 1, caractérisé en ce qu'il s'agit de la endo-9-méthyl-9-azabicyclo-[3,3,1 ]nonan-3-amine.
EP85115575A 1978-12-30 1979-12-20 Dérivés d'azabicycloalkyl Expired EP0220339B1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB7850380 1978-12-30
GB7850380 1978-12-30
GB7909262 1979-03-15
GB7909262 1979-03-15
GB7927831 1979-08-09
GB7927831 1979-08-09
EP79302978A EP0013138B1 (fr) 1978-12-30 1979-12-20 Dérivés azabicycloalcoyle, procédé pour leur préparation et compositions pharmaceutiques les contenant

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP79302978.6 Division 1979-12-20

Publications (2)

Publication Number Publication Date
EP0220339A1 EP0220339A1 (fr) 1987-05-06
EP0220339B1 true EP0220339B1 (fr) 1989-11-08

Family

ID=27260652

Family Applications (3)

Application Number Title Priority Date Filing Date
EP79302978A Expired EP0013138B1 (fr) 1978-12-30 1979-12-20 Dérivés azabicycloalcoyle, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP82109116A Expired EP0081054B1 (fr) 1978-12-30 1979-12-20 Dérivés azabicyclo alkylés
EP85115575A Expired EP0220339B1 (fr) 1978-12-30 1979-12-20 Dérivés d'azabicycloalkyl

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP79302978A Expired EP0013138B1 (fr) 1978-12-30 1979-12-20 Dérivés azabicycloalcoyle, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP82109116A Expired EP0081054B1 (fr) 1978-12-30 1979-12-20 Dérivés azabicyclo alkylés

Country Status (14)

Country Link
US (5) US4273778A (fr)
EP (3) EP0013138B1 (fr)
AR (1) AR225301A1 (fr)
AT (1) ATE24320T1 (fr)
AU (2) AU527837B2 (fr)
CA (2) CA1218062A (fr)
DE (3) DE2966476D1 (fr)
DK (1) DK553979A (fr)
ES (1) ES487379A0 (fr)
IE (2) IE49736B1 (fr)
IL (1) IL59004A0 (fr)
MX (1) MX6255E (fr)
NZ (1) NZ192476A (fr)
ZA (1) ZA797054B (fr)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
US4424358A (en) 1979-01-16 1984-01-03 Delalande S.A. β-3-Amino nor-tropane compounds
FR2476088A2 (fr) * 1979-01-16 1981-08-21 Delalande Sa Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
IL61642A0 (en) * 1979-12-20 1981-01-30 Beecham Group Ltd Aniline derivatives,their preparation and pharmalceutical compositions containing them
US4416683A (en) * 1980-09-16 1983-11-22 Eli Lilly And Company Benzamides, compositions and agricultural method
US5086184A (en) * 1980-09-16 1992-02-04 Dowelanco N-heterocyclic benzamides
US4943634A (en) * 1980-09-16 1990-07-24 Eli Lilly And Company N-heterocyclic benzamides
FR2493848B2 (fr) * 1980-11-07 1986-05-16 Delalande Sa Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
ZA818221B (en) * 1980-12-12 1982-10-27 Beecham Group Plc Pharmaceutical compounds
US4430435A (en) 1980-12-24 1984-02-07 Burroughs Wellcome Co. Assay system
EP0057536A1 (fr) * 1981-01-26 1982-08-11 Beecham Group Plc Composés à activité pharmaceutique
US4353922A (en) * 1981-03-13 1982-10-12 Syntex (U.S.A.) Inc. Anticholinergic bronchodilators
EP0067565A1 (fr) * 1981-06-16 1982-12-22 Beecham Group Plc Benzamides bicycliques, leur procédé de préparation et leur application
EP0069481A1 (fr) * 1981-06-17 1983-01-12 Beecham Group Plc Azabicycloalkylbenzamides, leur procédé de préparation et les compositions pharmaceutiques les contenant
EP0067615B1 (fr) * 1981-06-17 1986-01-08 Beecham Group Plc Dérivés thioalkyl d'azabicyclobenzamides, leur procédé de préparation et les compositions pharmaceutiques les contenant
EP0068699A1 (fr) * 1981-06-22 1983-01-05 Beecham Group Plc Décahydroquinolylbenzamides, leur procédé de préparation, et les compositions pharmaceutiques les contenant
EP0069482A1 (fr) * 1981-06-29 1983-01-12 Beecham Group Plc Azabicycloalkylenzamides, leur procédé de préparation et les compositions pharmaceutiques les contenant
EP0068700A1 (fr) * 1981-06-29 1983-01-05 Beecham Group Plc Azabicycloalkylbenzamides, leur procédé de préparation et les compositions pharmaceutiques les contenant
DE3275296D1 (en) * 1981-10-01 1987-03-05 Beecham Group Plc Azabicyclo-(3,3,1)-nonylbenzamide derivatives, processes for their preparation, and pharmaceutical compositions containing them
EP0083737A1 (fr) * 1981-12-15 1983-07-20 Beecham Group Plc N-azabicycloalcan benzamides, procédé de préparation et les compositions pharmaceutiques les contenant
EP0093488A3 (fr) * 1982-03-18 1984-05-23 Beecham Group Plc Composés nortropyl benzopyrrolinoniques, procédé pour leur préparation et compositions pharmaceutiques les contenant
IE56226B1 (en) * 1982-04-14 1991-05-22 Beecham Group Plc Substituted azabicyclo compounds,process for their preparation and pharmaceutical compositions containing them
ZA832549B (en) * 1982-04-14 1988-09-28 Beecham Group Plc Pharmaceutically active compounds
DE3368061D1 (en) * 1982-05-11 1987-01-15 Beecham Group Plc Azabicycloalkane derivatives, their preparation and medicaments containing them
AU1508183A (en) * 1982-06-04 1983-12-08 Beecham Group Plc Benzamide and anilide derivatives of 8-azabicyclo-(3.2.1)- -octane
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
EP0099194A3 (fr) * 1982-07-03 1984-04-11 Beecham Group Plc Benzamides
JPS5936675A (ja) * 1982-07-13 1984-02-28 サンド・アクチエンゲゼルシヤフト 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
EP0101641A3 (fr) * 1982-07-22 1984-03-28 Beecham Group Plc Dérivés sulphonylamino-aza-bicycloalkyles
EP0102195A3 (fr) * 1982-08-03 1984-04-11 Beecham Group Plc Dérivés d'azabicycloalkyle substitués doués d'une activité dopamine antagoniste
EP0126087A1 (fr) * 1982-09-24 1984-11-28 Beecham Group Plc Derives d'amino-azabicycloalkyle utilises en tant qu'antagonistes de la dopamine
GB8302483D0 (en) * 1983-01-29 1983-03-02 Beecham Group Plc Compounds
FR2546169B1 (fr) * 1983-05-20 1986-03-21 Delalande Sa N-oxydes de derives aminocycliques, leur procede de preparation et leur application en therapeutique
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2548666A1 (fr) * 1983-07-08 1985-01-11 Delalande Sa Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
DE3581725D1 (de) * 1984-12-14 1991-03-14 Hoechst Roussel Pharma Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3587151T2 (de) * 1984-12-20 1993-07-15 Sandoz Ag Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.
US4698217A (en) * 1985-02-26 1987-10-06 Mobil Oil Corporation Crystalline silicate ZSM-58 and process for its preparation using a methyltropinium cation
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8516371D0 (en) * 1985-06-28 1985-07-31 Beecham Group Plc Compounds
GB8518236D0 (en) * 1985-07-19 1985-08-29 Beecham Group Plc Compounds
EP0220011A3 (fr) * 1985-10-12 1990-01-03 Beecham Group Plc Utilisation des azabicycloalkylbenzamides pour le traitement des maladies de la motilité gastro-intestinale, migraine, émésis, céphalalgie de la migraine, neuralgie trigéminale et arrhythmie
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
AT396870B (de) * 1986-08-07 1993-12-27 Sandoz Ag Verfahren zur herstellung einer galenischen formulierung zur nasalen verabreichung von serotoninantagonisten
DE3629598A1 (de) * 1986-08-30 1988-03-03 Boehringer Ingelheim Kg 3-brom-2,6-dimethoxibenzamide, ihre herstellung und verwendung
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
GB8727989D0 (en) * 1987-11-30 1988-01-06 Merck Sharp & Dohme Therapeutic agents
US5880260A (en) * 1988-11-18 1999-03-09 Oregon Health Sciences University Dopamine receptors and genes
EP0447483B1 (fr) * 1988-11-18 1997-06-18 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of Recepteurs de dopamine et genes
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents
US5070094A (en) * 1989-09-05 1991-12-03 G. D. Searle & Co. N-benzyltropaneamides
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
EP0494140A4 (en) * 1989-09-27 1992-09-02 Rorer International (Holdings), Inc. Dibenzofurancarboxamides
US5223613A (en) * 1990-04-27 1993-06-29 G. D. Searle & Co. Azatetracycle compounds and process of preparing same
US5140023A (en) * 1990-04-27 1992-08-18 G. D. Searle & Co. Azatetracycle compounds
US5236932A (en) * 1990-07-19 1993-08-17 E. R. Squibb & Sons, Inc. Method for treating Parkinson's disease employing quinine
US5240146A (en) * 1990-12-14 1993-08-31 Smedley William H Variable proportion dispenser
IL100432A (en) * 1990-12-27 1996-01-19 Erba Carlo Spa Dihydrobenzopuran carboxamides, their preparation and pharmaceutical preparations containing them
EP0566609A1 (fr) * 1991-01-09 1993-10-27 Smithkline Beecham Plc Derives azabicydiques et azatricydiques, leurs procedes et intermediaires de preparation et compositions pharmaceutiques les contenant
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
US5219850A (en) * 1991-03-07 1993-06-15 G. D. Searle & Co. Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5227377A (en) * 1991-03-07 1993-07-13 G. D. Searle & Co. Meso-azacyclic amides of certain bicyclic carboxylic acids
US5137893A (en) * 1991-03-07 1992-08-11 G. D. Searle & Co. Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5196547A (en) * 1991-03-07 1993-03-23 G. D. Searle & Co. Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5516782A (en) * 1991-03-07 1996-05-14 G. D. Searle & Co. New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
AU1578692A (en) * 1991-03-07 1992-10-06 G.D. Searle & Co. New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
US5234921A (en) * 1991-03-07 1993-08-10 G. D. Searle & Co. Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof as pharmaceuticals
DE69319939T2 (de) * 1992-02-04 1999-02-18 Eisai Co., Ltd., Tokio/Tokyo Aminobenzoesäure Derivate
IT1255467B (it) * 1992-07-29 1995-11-02 Dompe Farmaceutici Spa Ammidi acriliche farmacologicamente attive
GB9404055D0 (en) * 1994-03-03 1994-04-20 Smithkline Beecham Plc Novel process
US5625065A (en) * 1994-06-27 1997-04-29 Eli Lilly And Company Stereoselective process for making endo-tropanamine and like compounds
GB9414900D0 (en) * 1994-07-23 1994-09-14 Smithkline Beecham Plc Novel process
DK0984943T3 (da) 1997-05-30 2003-03-17 Neurosearch As Azacycloalkan og -alkenderivater, deres fremstilling og anvendelse
ATE231861T1 (de) 1997-05-30 2003-02-15 Neurosearch As 9-azabicyclo(3.3.1)non-2-ene und nonanderivate als liganden der nicotinergen rezeptoren
UA58476C2 (uk) * 1997-10-09 2003-08-15 Санофі-Сентелябо Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб
FR2769628B1 (fr) * 1997-10-09 1999-11-12 Synthelabo Derives de n-(2,3-dihydro-1h-inden-2-yl)-n-propyl-8- azabicyclo[3.2.1.]octane-3-methanamine, leur preparation et leur application en therapeutique
IT1313660B1 (it) * 1999-10-01 2002-09-09 Dompe Spa Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
FR2831884B1 (fr) 2001-11-02 2003-12-26 Pf Medicament Nouveaux derives amides heteroaromatiques de 3 beta-amino azabicyclooctane, leur procede de preparation et leurs applications en therapeutique
HUP0202001A2 (hu) * 2002-06-14 2005-08-29 Sanofi-Aventis DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
AU2003276919B2 (en) 2002-09-25 2013-05-16 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
AU2004215679A1 (en) 2003-02-27 2004-09-10 F. Hoffmann-La Roche Ag CCR-3 receptor antagonists
RS20060391A (en) 2003-12-22 2008-11-28 Memory Pharmaceuticals Corporation, Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof
CN103724343A (zh) 2004-03-25 2014-04-16 记忆药物公司 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑及其制备和用途
JP2007534692A (ja) 2004-04-22 2007-11-29 メモリー・ファーマシューティカルズ・コーポレイション インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用
RU2386633C2 (ru) 2004-05-07 2010-04-20 Мемори Фармасьютиклз Корпорейшн 1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
CA2591817A1 (fr) 2004-12-22 2006-06-29 Memory Pharmaceuticals Corporation Ligands du recepteur alpha-7 nicotinique ainsi que preparation et utilisations de ceux-ci
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
ES2400875T3 (es) * 2008-04-11 2013-04-15 Janssen Pharmaceutica N.V. Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno A4 hidrolasa
NZ596137A (en) 2009-05-14 2013-08-30 Janssen Pharmaceutica Nv Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
CN104860946A (zh) * 2015-05-14 2015-08-26 湖北生物医药产业技术研究院有限公司 Ccr5拮抗剂的制备方法
MX2020008195A (es) * 2018-02-05 2020-11-24 Alkermes Inc Compuestos para el tratamiento del dolor.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774858A (en) * 1954-10-20 1957-05-15 Sandoz Ltd Tropane and -Î-tropane derivatives and process for preparation thereof
GB1593146A (en) * 1976-11-05 1981-07-15 Beecham Group Ltd Octahydro-quinolizinyl benzamide derivatives
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
US4424358A (en) * 1979-01-16 1984-01-03 Delalande S.A. β-3-Amino nor-tropane compounds
FR2446823A1 (fr) * 1979-01-16 1980-08-14 Delalande Sa Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
DK553979A (da) 1980-08-15
EP0081054B1 (fr) 1986-12-17
US4273778A (en) 1981-06-16
CA1218062A (fr) 1987-02-17
MX6255E (es) 1985-02-15
IL59004A0 (en) 1980-03-31
US4599420A (en) 1986-07-08
DE2967692D1 (de) 1989-12-14
AU9135182A (en) 1983-03-10
NZ192476A (en) 1982-09-14
ES8101072A1 (es) 1980-12-01
IE792524L (en) 1980-06-30
EP0013138A1 (fr) 1980-07-09
DE2966476D1 (en) 1984-01-12
IE49737B1 (en) 1985-12-11
EP0081054A3 (en) 1983-08-24
AU527837B2 (en) 1983-03-24
US4705858A (en) 1987-11-10
AU5425579A (en) 1980-07-03
AU543825B2 (en) 1985-05-02
US4544660A (en) 1985-10-01
AR225301A1 (es) 1982-03-15
ZA797054B (en) 1980-12-31
ES487379A0 (es) 1980-12-01
DE2967642D1 (de) 1987-01-29
ATE24320T1 (de) 1987-01-15
CA1220473A (fr) 1987-04-14
US4336259A (en) 1982-06-22
EP0013138B1 (fr) 1983-12-07
IE49736B1 (en) 1985-12-11
EP0220339A1 (fr) 1987-05-06
EP0081054A2 (fr) 1983-06-15

Similar Documents

Publication Publication Date Title
EP0220339B1 (fr) Dérivés d&#39;azabicycloalkyl
US5017582A (en) Method of inducing a serotonin M receptor antagonist effect with N-quinuclidinyl-benzamides
US4569940A (en) Certain 5-N-mono- or disubstituted sulfamoyl benzamides having use in treatment of emesis, impaired gastro-intestinal motility disorders and central nervous system disorders
HU202527B (en) Process for producing new quinuclidine derivatives and pharmaceutical compositions comprising same
WO1991004252A1 (fr) Nouveaux esters d&#39;acides carboxyliques de thienyle et aminoalcools, leurs produits de quaternisation ainsi que fabrication et emploi de ces composes
SU797578A3 (ru) Способ получени производных бензо-диАзЕпиНОНА или иХ СОлЕй
US4735944A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes, and their use in mental therapy
US3705907A (en) 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives
US4353922A (en) Anticholinergic bronchodilators
NZ197581A (en) Preparation of trans-4a,9b-5-aryl-2-(-hydroxy- - phenyl-alkyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3,b)-indoles and 5-phenyltetrahydrofuran-2-ol precursors therin
EP0021580B1 (fr) Dérivés de sulfonamides, procédé pour leur préparation et leur application comme médicaments
CA2261692A1 (fr) Esters d&#39;arylcycloalcane carboxyliques, leur emploi, leur preparation et leurs compositions pharmaceutiques
US4888335A (en) 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
IE50885B1 (en) 1-phenyl-2-cyclohexene-1-alkylamine derivatives,a process for their preparation and medicaments containing them
US4272533A (en) N-Phenylindoline derivatives, and pharmaceutical compositions containing them
US3065230A (en) Azabicyclohexanes and method of preparing them
US4341789A (en) Cycloaliphatic prostaglandin analogues
US3211792A (en) 1-(phenyl)-or 1-(alkyl-substitutedphenyl)-5-(substituted-phenyl)-3-aza penta-(1)-ols and salts thereof
US3884976A (en) 7-Amino norbornane derivatives
US3032556A (en) Process for the preparation of new
US3929902A (en) 1-Phenyl-2, 3-butadien-1-ols
CA1124731A (fr) Amides cycliques alkyles
US4769373A (en) Anti-arrhythmic azabicyclic compounds
EP0772613B1 (fr) Procede de production d&#39;aminoazobicycoalcanes a partir d&#39;oximes
CA1131236A (fr) Procedes d&#39;obtention de derives de 2,9-dioxatricyclo [4,3,1,0 su3,7 xx] decane et substances pharmaceutiques qui en contiennent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19860104

AC Divisional application: reference to earlier application

Ref document number: 13138

Country of ref document: EP

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT NL SE

17Q First examination report despatched

Effective date: 19880823

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 13138

Country of ref document: EP

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE CH DE FR GB IT NL SE

REF Corresponds to:

Ref document number: 2967692

Country of ref document: DE

Date of ref document: 19891214

ET Fr: translation filed
ITF It: translation for a ep patent filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19901214

Year of fee payment: 12

ITTA It: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19910115

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19911221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Effective date: 19911231

BERE Be: lapsed

Owner name: BEECHAM GROUP P.L.C.

Effective date: 19911231

REG Reference to a national code

Ref country code: FR

Ref legal event code: CC

Free format text: FRCC 92C0135, 920430

REG Reference to a national code

Ref country code: FR

Ref legal event code: CB

Free format text: FRCB 92C0135, 791220

MEDD It: supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 167, 19920424; BBECHAM GROUP PLC

REG Reference to a national code

Ref country code: FR

Ref legal event code: CL

EUG Se: european patent has lapsed

Ref document number: 85115575.4

Effective date: 19920704

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19980914

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19981110

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19981203

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19981221

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19981230

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 19991219

Ref country code: CH

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 19991219

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 19991220

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Effective date: 19991219

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLV7 Nl: ceased due to reaching the maximum lifetime of a patent

Effective date: 19991220